Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-09-10FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA has granted a supplemental approval for insulin lispro submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS research · 2015-09-10Clinical Trial Update: Guided Self-determination - Promoting Self-management in Type 1 Diabetes [NA]
Clinical trial update describing a study on guided self-determination to promote self-management in Type 1 diabetes.
-
CLINICAL_TRIALS trial_result · 2015-09-09Clinical Trial Update: Profiling of Original Cellular and Humoral Biomarkers of Type 1 Diabetes [NA]
A completed clinical trial profiling cellular and humoral biomarkers in individuals with Type 1 diabetes.
-
CLINICAL_TRIALS trial_result · 2015-08-24Clinical Trial Update: Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children [Phase 2]
A Phase 2 trial in children with Type 1 diabetes evaluated predictive algorithms paired with insulin pump suspension to reduce nocturnal hyp…
-
CLINICAL_TRIALS trial_result · 2015-08-24Clinical Trial Update: Treatment With Erythropoietin and Cognition During Hypoglycaemia [NA]
An update on a trial evaluating erythropoietin for cognition during hypoglycemia in people with Type 1 diabetes mellitus.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-08-21Clinical Trial Update: Hematopoietic Stem Cell Support Versus Insulin in T1D [Phase 1, Phase 2]
Phase 1/2 trial evaluating hematopoietic stem cell support as an alternative to insulin in Type 1 diabetes, which has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: Physical Activity in Children With Type 1 Diabetes Study [NA]
A completed clinical trial studying physical activity in children with Type 1 Diabetes Mellitus; results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Improved Glycemic Control in Adult Subjects With Type 1 Diabetes on MDI Using Insulin Guidance Software
Completed clinical trial evaluating insulin guidance software in adults with type 1 diabetes on multiple daily injections showed improved gl…
-
FDA approval · 2015-08-07FDA Approved: SYMLINPEN — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SYMLINPEN (pramlintide acetate) from AstraZeneca.
-
CLINICAL_TRIALS trial_result · 2015-08-07Clinical Trial Update: Importance in Type 1 Diabetes Patients of an Optimized Control of Post-Prandial Glycaemia on Oxidant Stress Prevention [NA]
A completed clinical trial examining whether optimized control of post-prandial glycemia reduces oxidative stress in patients with Type 1 di…
-
CLINICAL_TRIALS trial_result · 2015-08-06Clinical Trial Update: Paramedical Consultation in Telemedicine
A terminated clinical trial update regarding paramedical consultation in telemedicine for individuals with type 1 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2015-08-03Clinical Trial Update: An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 1 Diabetes Mellitus [Phase 3]
This document reports the results of a Phase 3 open-label study comparing Insulin VIAject with Regular Human Insulin in patients with Type 1…
-
CLINICAL_TRIALS trial_result · 2015-08-03Clinical Trial Update: To Evaluate the Effect on Post-prandial Glycemia Safety, and Tolerability of Viaject 7 vs. Lispro Insulin During Subcutaneous Insulin Pump Therapy [Phase 3]
Phase 3 trial comparing Viaject 7 to insulin lispro in type 1 diabetes patients using insulin pumps, evaluating post-prandial glycemia safet…
-
CLINICAL_TRIALS trial_result · 2015-07-31Clinical Trial Update: A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continuous Glucose Monitor (GBP CGM) [Phase 2]
A Phase 2 study evaluating the performance of a glucose blinding protein-based continuous glucose monitor (GBP CGM) in individuals with Type…
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital [Phase 2, Phase 3]
The study reports the completed Phase 2/Phase 3 validation of the Diabeloop artificial pancreas algorithm used in hospital settings for Type…
-
CLINICAL_TRIALS research · 2015-07-30Clinical Trial Update: DKA Optic Ultrasound
This is a clinical trial update about using optic ultrasound in diabetic ketoacidosis. The sponsor is Children's Hospitals and Clinics of Mi…
-
CLINICAL_TRIALS trial_result · 2015-07-29Clinical Trial Update: A Study Evaluating the Bioequivalence of VIAject®7 Compared to VIAject®25 and Comparing the Pharmacokinetic and Pharmacodynamic Properties of VIAject®7 to Insulin Lispro in Subjects With Type 1 Diabetes Mellitus [Phase 1, Phase 2]
A Phase 1/Phase 2 trial reports on the bioequivalence of VIAject 7 to VIAject 25 and compares the pharmacokinetic and pharmacodynamic proper…
-
CLINICAL_TRIALS trial_result · 2015-07-29Clinical Trial Update: An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ in Subjects With Type 1 Diabetes Mellitus [Phase 3]
This open-label, multicenter Phase 3 follow-on study assesses the long-term safety and efficacy of Insulin VIAject in subjects with Type 1 d…
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®) [Phase 2]
A Phase 2 trial evaluated the safety and efficacy of BIOD-123 compared with insulin lispro (Humalog) in individuals with Type 1 Diabetes Mel…
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Safety Study to Assess Whether Proinsulin Peptide Injections Can Slow or Stop the Body Damaging Its Own Insulin-making Cells in the Pancreas in Patients Newly Diagnosed With Type 1 Diabetes [Phase 1, Phase 2]
Completed Phase 1/2 safety study evaluating injections of proinsulin peptide to slow autoimmune destruction of insulin-producing cells in pe…
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Metabolic Effects of Accurate Blood Sugar Results and Education in Type 1 Diabetes [Phase 4]
A Phase 4 clinical trial update assessing the metabolic effects of providing accurate blood glucose results and education in Type 1 diabetes…
-
FDA approval · 2015-07-17FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for Lantus SoloStar (insulin glargine) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2015-07-15FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2015-07-13Clinical Trial Update: GIP and GLP-1 in Type 1 Diabetes [NA]
A completed clinical trial evaluating the use of GIP and GLP-1 in individuals with Type 1 diabetes to address hypoglycemia.
-
FDA approval · 2015-06-24FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
The FDA approved a supplemental application for Afrezza (insulin human) from MannKind Corporation. This approval updates the label/indicatio…